IRD vs REGN: Which Stock is Better?
Side-by-side comparison of Opus Genetics Inc and Regeneron Pharmaceuticals Inc in 2026
IRD
Opus Genetics Inc
$5.71
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | IRD | REGN | Winner |
|---|---|---|---|
| Market Cap | $396.30M | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | -0.1% | 0.0% | REGN |
| Gross Margin | -117.0% | 44.6% | REGN |
Analyze IRD
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRD or REGN a better investment?
Comparing IRD and REGN: Opus Genetics Inc has a market cap of $396.30M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRD and REGN?
IRD (Opus Genetics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRD or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRD or REGN?
REGN has higher revenue growth at 0.0% vs -0.1% for IRD.
Which company is more profitable: IRD or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -117.0% for IRD.
Which is the larger company: IRD or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $396.30M for IRD.
Should I buy IRD or REGN in 2026?
Both IRD and REGN have investment merit. IRD trades at $5.71 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRD and REGN stock?
Key differences: Market Cap ($396.30M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (-117.0% vs 44.6%).